Future Fertility Inc. is a Canada-based artificial intelligence (AI) med-tech startup focused on reproductive innovations with image analysis software tools (VIOLET™ & MAGENTA™) that evaluate the reproductive potential of human eggs (oocytes).

Our non-invasive and instantaneous image analysis tools require only a single image of an egg taken from a standard light microscope. VIOLET™ can predict whether an egg will successfully fertilize with 90% accuracy and the chance of it reaching a blastocyst with almost 65% accuracy.

These clinically validated tools provide objective insights into egg quality to empower patients, doctors, and embryologists, enabling personalized patient feedback, tailored treatment plans, and improved IVF outcomes.

Our mission is to bring the power of AI to collaborate with fertility professionals, optimize reproductive care, and empower patients at all stages of their fertility journey.

Our vision is to unlock the future of personalized fertility care worldwide.

We have a team of innovators and experts in data science, machine learning, reproductive endocrinology, embryology, clinical research, user-experience design, and customer service.

Key leadership includes Christy Prada, CEO; Dr. Dan Nayot, Chief Medical Officer and Co-Founder; and Alex Krivoi, CTO and Co-Founder.

Future Fertility's AI models have been clinically validated in collaboration with leading fertility clinics, with findings published in peer-reviewed journals and numerous abstracts presented at international conferences.